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The adrenal gland is located deep in the retroperito-
neum beneath the diaphragm. Open surgery via ante-
rior transabdominal, posterior and flank approaches, is
difficult and technically demanding, and is associated
with complications and lengthy convalescence. Since
the first report on laparoscopic adrenalectomy (LA)
by Gagner et al in 1992 [1], the laparoscopic approach
has become the preferred technique to remove benign
functioning and non-functioning tumors of the adre-
nal gland. However, there are very few head-to-head
comparisons between laparoscopic and open meth-
ods at the same institution. The objectives of this study
are to report our experience and the benefits of mini-
mally invasive techniques in adrenalectomy. We retro-
spectively evaluated the operative and postoperative
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The role of laparoscopy in the management of adrenal tumors is well established. However, there
are very few head-to-head comparisons between laparoscopic and open methods at the same
institution. We retrospectively evaluated the operative and postoperative parameters of laparo-
scopic adrenalectomy for adrenal tumors and compared the results with those of traditional open
adrenalectomy. Eighty-eight patients with adrenal tumors underwent adrenalectomy between
January 1997 and October 2008 at our institute. Clinical data were retrospectively collected after
assigning the patients into Group I (n = 51), who underwent the laparoscopic method, and Group
II (n = 37), who underwent the traditional open method, by reviewing the patients’ charts and
related data. Patients in Group I experienced significantly less blood loss (88.6 ± 93.0 mL vs.
321.4 ± 265.4 mL, p < 0.01), shorter hospital stay (6.7 ± 4.3 days vs. 11.3 ± 5.4 days, p < 0.01) and earlier
oral intake (1.5 ± 0.6 days vs. 2.2 ± 0.8 days, p < 0.01) postoperatively. In Group I, eight patients had
adrenal tumors larger than 6 cm and no statistically significant differences were found compared
with the other patients in Group I. Two patients in Group I had malignancies and no local or 
port site recurrence was found at regular follow-up. There was no mortality in either group.
Laparoscopic adrenalectomy is a safe, effective and minimally invasive approach with the advan-
tages of better cosmesis, less blood loss, shorter hospital stay and more rapid recovery. We recom-
mend that laparoscopic adrenalectomy is considered as the gold standard procedure for adrenal
tumors, irrespective of whether the tumor is benign or malignant.
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parameters of LA for adrenal tumors and compared
the results with those of traditional open adrenalec-
tomy (OA).
PATIENTS AND METHODS
Eighty-eight patients with adrenal tumors undergoing
adrenalectomy between January 1997 and October
2008 were enrolled in this study at our institute. Fifty-
one patients who underwent LA were assigned to
Group I while 37 patients who underwent OA were
assigned to Group II. The choice between laparo-
scopic or open surgery was made according to the
clinical condition, the patient’s preference and the sur-
geon’s professional specialty. Data from both groups
were compared.
In Group I, the laparoscopic procedures have been
performed since February 2001 with either lateral
transabdominal adrenalectomy (LTA) or retroperi-
toneal endoscopic adrenalectomy (REA), as selected
by the surgeons. At least three trocars were inserted,
including one camera trocar to insert a 30º laparo-
scope and two working trocars. The camera trocar
was placed over the periumbilical area in the LTA
and 2 cm above the iliac crest in the midaxillary line
in the REA. Pneumoperitoneum or pneumoretroperi-
toneum up to 12–15 mmHg in pressure was estab-
lished with CO2 insufflation. The adrenal gland was
mobilized carefully from its lateral and posterior attach-
ments using a harmonic scalpel and the adrenal ves-
sels were clipped with titanium clips and divided. At
the end of the procedure, the specimen was removed
via one of the ports, which was extended according
to the tumor size. By contrast, the open surgical pro-
cedure in Group II was performed via anterior trans-
abdominal, posterior and flank approaches, with a
transperitoneal or retroperitoneal incision line of
15–20 cm in length.
The operating time was recorded in laparoscopic
operations as the time from insertion of the Veress
needle for insufflation to skin closure and in open
operations as the time from skin incision to comple-
tion of skin closure. Blood loss was estimated by
swab weight and/or suction volume. The charts and
data, including demographic details, intraoperative
and postoperative data, were reviewed retrospec-
tively. Statistical analyses for between-group compar-
isons were performed using the Mann-Whitney U test.
A two-tailed p value of < 0.05 was considered statisti-
cally significant.
RESULTS
Fifty-one of the 88 patients with adrenal tumors
underwent LA (Group I), of whom 13 underwent
LTAs and 38 underwent REAs; 37 of the 88 patients
underwent OA (Group II). The patients in both groups
were included over the same period of time. Variables
including age, tumor size, operation time, postopera-
tive hospital stay, time to oral intake and complica-
tions with blood loss were compared between both
groups. Table 1 lists the demographic data, characteris-
tics of the adrenal tumor and perioperative parameters.
There were no significant differences in terms of
age (mean ± standard deviation; 45.2 ± 10.9 years vs.
46.4 ± 15.7 years), tumor size (3.8 ± 1.7 cm vs. 4.5 ±
2.3 cm) and operation time (158.6 ± 53.6 minutes vs.
149.6 ± 62.8 minutes). Group I patients experienced
significantly less blood loss (89 ± 92.9 mL vs. 321±
265.4 mL, p<0.01), shorter postoperative hospital stay
(6.7 ± 4.3 days vs. 11.3 ± 5.4 days, p < 0.01) and earlier
oral intake (1.5 ± 0.6 days vs. 2.2 ± 0.8 days, p < 0.01). 
Table 1. Demographic data, characteristics and perioperative parameters of the adrenal tumors*
Group I (laparoscopic adrenalectomy) Group II (open adrenalectomy) p†
Number of patients 51 37 –
Age (yr) 45.2 ± 10.9 46.4 ± 15.7 0.72
Postoperative stay (d) 6.7 ± 4.3 11.3 ± 5.4 < 0.01
Tumor size (cm) 3.8 ± 1.7 4.5 ± 2.3 0.13
Operation time (min) 158.6 ± 53.6 149.6 ± 62.8 0.21
Blood loss (mL) 88.6 ± 93.0 321.4 ± 265.4 < 0.01
Time to oral intake (d) 1.5 ± 0.6 2.2 ± 0.8 < 0.01
*Data presented as mean ± standard deviation; †Mann-Whitney U test.
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In terms of complications, one episode of spleen injury,
one episode of pancreas tail injury and one episode
of liver injury were reported in Group I. Argon beam
coagulation was used to control the mild liver and
spleen bleeding. The pancreas tail injury was treated
by suture and drainage placement. Conversion to open
surgery was required in one patient in Group I because
of a huge pheochromocytoma with uncontrolled intra-
operative hypertension. One episode of paralytic ileus,
one episode of wound infection and one episode of
liver injury were reported in Group II. Blood transfu-
sion was needed in two patients in Group II. There
was no re-operation or mortality in either group.
With respect to pathologic diagnosis, 30 of the 88
patients (34.1%) had adrenocortical adenoma with hy-
peraldosteronism, so called aldosteronoma or Conn’s
disease. Eighteen patients (20.5%) had adrenocortical
adenoma with Cushing’s syndrome. Seventeen patients
(19.3%) had pheochromocytoma. Other pathologic
types, sorted by the percentage, were non-functioning
adenoma (10.2%), metastases (5.7%), myelolipoma
(3.4%), adenocarcinoma (2.3%), androgen-producing
adenoma (2.3%), adrenal cyst (1.1%) and lymphoma
(1.1%). The types of pathology and prevalence of the
adrenal tumors are shown in Table 2.
DISCUSSION
LA has become the treatment of choice to remove
benign functioning and non-functioning tumors of
the adrenal glands. Compared with open procedures,
our data revealed that LA was associated with signif-
icantly less blood loss, shorter postoperative hospital
stay and earlier oral intake. Multiple retrospective
comparative studies and case series have confirmed
these benefits of minimally invasive surgery for ad-
renal tumors [2–6]. LA also has advantages such as 
better cosmesis, use of fewer analgesics, higher pa-
tient satisfaction, decreased morbidity, and markedly
better economics, shorter hospital stay with reduced
hospital costs and earlier return to regular work and
activities.
More than 75% of LAs are performed to treat
endocrine causes of hypertension such as aldos-
teronoma, Cushing’s syndrome and disease, and
pheochromocytoma [7]. These were consistent with
our finding in terms of pathology and diagnosis. In
our study, 34.1% of patients had aldosteronoma, which
initially presented with hypokalemia and hyperten-
sion. Our results demonstrate successful outcomes
with LA for aldosteronoma. Postoperatively, most of
the patients reverted to normokalemia and showed
improvements in hypertension. Removing aldo-
steronoma by LA has also been reported to have excel-
lent results with low morbidity and mortality [8].
Some authors have even suggested that LA can be
performed as an outpatient procedure in the man-
agement of aldosterone-secreting adrenal adenoma
[9]. Hypokalemia is uniformly cured; however, per-
sistent hypertension has been reported with return-
to-normal hormone levels postoperatively. The rates
of postoperative hypertension are similar to those
with open surgery and can be as high as 34% [10,11].
Almost all adrenal tumors can be resected by min-
imally invasive approaches. However, some limita-
tions of LA include adrenal tumors larger than 6 cm,
pheochromocytomas and malignant neoplasms [12,13].
It is still unclear whether laparoscopic resection is
appropriate for large (> 6 cm) potentially malignant
adrenal tumors because of the risk of incomplete re-
section and local recurrence. The average tumor size
in the LA group in our study was 3.8 cm (1.3–8.5 cm).
Eight patients in the LA group had adrenal tumors
larger than 6 cm. No statistically significant differ-
ence was found between these eight patients and the
other patients in the LA group. This was consistent
with other studies. Parnaby et al reported 39 patients
with adrenal tumor > 6 cm who underwent LA [14];
there were no significant differences between the
Table 2. Pathologic characteristics and prevalence of
adrenal tumors
Pathologic type n (%)
Adrenocortical adenoma 59 (67.1)
Aldosteronoma (Conn’s disease) 30 (34.1)
Cushing’s syndrome 18 (20.5)
Androgen-secreting adenoma 2 (2.3)
Non-functioning incidentaloma 9 (10.2)
Pheochromocytoma 17 (19.3)
Metastases 5 (5.7)
Myelolipoma 3 (3.4)
Adenocarcinoma 2 (2.3)
Adrenal cyst 1 (1.1)
Lymphoma 1 (1.1)
Total 88 (100)
median total anesthetic time, postoperative compli-
cations or postoperative hospitalization comparing
the patients who underwent LA for tumors > 6 cm
versus tumors < 6 cm. There was no evidence of local
recurrence. Although contemporary series suggest
that minimally invasive surgery is a reasonable ther-
apeutic modality for larger adrenal masses [15,16],
LA for these large masses is a technically demanding
procedure that should only be undertaken by experi-
enced laparoscopic surgeons who are familiar with
retroperitoneal anatomy and who are adept with vas-
cular techniques in the event of an open conversion.
LA should be avoided if there is evidence of peri-
adrenal infiltration preoperatively, and it is necessary
to convert the patient to an open approach because of
the difficulty in dissection caused by adhesion and fix-
ation of the mass or local tissue reaction, and because
of the risk of damaging the capsule of the potential
malignancy [17].
The final diagnosis of 17 patients (19%) in our
study was pheochromocytoma. Pheochromocytoma
is a catecholamine-producing neoplasm of the adrenal
medulla and is a major cause of correctable hyperten-
sion and its prevalence was 0.1–0.5% in a population of
patients with hypertension [18]. Intraoperative hyper-
tensive or hypotensive episodes were often observed
in these cases. The hemodynamic changes during LA
for pheochromocytoma, compared with those during
open surgery, have received considerable attention.
In our experience, there were no statistically signif-
icant differences between the LA and OA groups.
Series review has shown that the minimally invasive
approach leads to similar or fewer hemodynamic fluc-
tuations when compared with the open technique
[19,20]. This finding may be due to the added role 
of anesthesiologists during laparoscopy to better
observe the operation and control the patients’ blood
pressure. Several comparative studies of LA versus
OAfor pheochromocytoma have been reported [21–23].
Advantages of LA over OA were observed in terms
of mean operating time, hospital stay, need for inten-
sive care, intraoperative hypertension, intraoperative
blood loss, postoperative analgesia and return to oral
nutrition.
Laparoscopic removal of the adrenal malignancy
raised the concern that the laparoscopic approach
may result in inadequate removal of malignant adre-
nal tumors and increase the risk of local and port-site
recurrences [24]. Seven patients (8%) in our series were
malignant, five (5.7%) had metastases and two (2.3%)
had primary adrenal carcinoma; only two patients
received LA. In these two patients who underwent LA,
no recurrence was found during the regular follow-
up. Reviewing the report by McCauley et al [25], LA
for primary adrenal malignancy can provide onco-
logic outcomes that are equivalent to open surgery
but without an increased risk of carcinomatosis or
port-site recurrence. Although long-term survival for
up to 47 months with no recurrence has been reported,
the underlying aggressiveness of this tumor has con-
tributed to a rate of recurrence of 39.6% for the con-
temporary cases reviewed in this article. An evaluation
of open approaches revealed a similar or higher recur-
rence rate. When used to treat solitary metastases to
the adrenal gland, LA provides oncologic outcomes
that are equivalent to OA. LA for malignancy can be
performed in appropriately selected cases with onco-
logic outcomes that are equivalent to open approaches,
while providing advantages in terms of patient mor-
bidity. Caution must be taken to avoid damaging the
tumor or leaving tumor tissue in situ because of the
potential for local recurrence, port-site recurrence and
carcinomatosis that can occur with these aggressive
tumors [26].
In our case review, three cases in the LA group
experienced organ injury and two patients in the OA
group needed blood transfusion. However, our study
still demonstrates the significantly reduced blood
loss with LA compared with OA. Laparoscopy offers
advantages in terms of better surgical view for a deep
operative field, such as the adrenal gland, and allows
magnification of structures and even small bleeds.
Nevertheless, bleeding is the most common compli-
cation during and after LA, and accounts for approx-
imately 40% of all complications [6]. It may occur
when a vessel or an organ is injured. Other reported
postoperative complications for LA include wound
infection or hematoma, and hernia in the long-term, in
addition to thromboembolic, urinary, gastrointestinal,
pulmonary and cardiovascular problems. Complica-
tions specific to laparoscopy include severe hypercar-
bia and acidosis, port-site bleeding and hernia.
The mean lengths of postoperative hospital stay in
the two groups were 6.7 days and 11.3 days, respec-
tively. This is much longer than that in most Western
countries. The most likely reason for this difference
stems from health insurance policy. Under the National
Health Insurance Act, the insurance premiums are low
Laparoscopic adrenalectomy
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and most of the medical cost is covered by insurance
in Taiwan. The patients are not normally discharged
until they feel that they have recovered completely.
There are some limitations of this study. Most of the
urologists at our institution can perform both laparo-
scopy and open surgery. Preference and specialty
exist among the urologists, which may offer advan-
tages and lead to positive outcomes in both the LA and
OA groups. It may not change the statistical results of
the comparison between the two groups. However,
urologists at our institution have different experience
in performing laparoscopy, which may contribute to
the different outcomes in the parameters of LA ver-
sus OA. LA is associated with a learning curve effect
and is operator-dependent. Several studies show that,
with increased experience, operating time continues
to decrease [27,28]. The operating time with experi-
enced laparoscopy surgeons should be less compared
with that in current LA group. The operation time
may be another factor that is associated with the sta-
tistically significant differences between LA and OA
when performed by experienced laparoscopic sur-
geons. On the other hand, selecting LA may consti-
tute a selection bias because patients with smaller
and benign lesions are favorable for laparoscopy. More
well-designed comparative studies and studies with
large numbers of patients are needed.
LA is a safe, effective and minimally invasive
approach that offers advantages such as better cosme-
sis, less blood loss, shorter hospital stay and rapid
recovery for the treatment of adrenal tumors. We
suggest that LA is the gold-standard procedure for
adrenal tumors, irrespective of whether the tumor is
benign or malignant.
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針對腎上腺腫瘤腹腔鏡腎上腺切除手術與
傳統手術之比較
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針對腎上腺腫瘤之治療，腹腔鏡手術的角色已逐漸被肯定。然而在同一醫療機構內直
接比較腹腔鏡與傳統腎上腺切除手術之文獻仍相當有限。本研究以回朔之方式收集並
評估腎上腺切除手術之術前、術中及術後之各項因子，比較腹腔鏡及傳統手術針對腎
上腺腫瘤治療之差異。從 1997 年 1 月至 2008 年 10 月，共有 88 位病人接受腎上腺
切除手術。病人依其手術方式分成兩組，第一組為腹腔鏡手術，共 51 人 ; 第二組為傳
統手術，共 37 人。結果顯示接受腹腔鏡手術之病人明顯有較少之出血量、較短之住
院天數、及較早恢復進食。腹腔鏡手術病人中有 8 位其腫瘤大於 6 公分，與同組病人
比較起來，術後恢復狀況並無顯著之差異。腹腔鏡手術病人中有兩位其病理報告為惡
性腫瘤，長期追蹤之下並無局部或手術切口復發之情形。無手術死亡之病例。腹腔鏡
腎上腺切除手術是一種安全有效之微創手術，並具有傷口美觀、出血量少、住院天數
短及恢復快等優點。因此我們建議不論良性或惡性腎上腺腫瘤，腹腔鏡腎上腺切除手
術為標準治療方式。
關鍵詞：腎上腺腫瘤、腎上腺切除手術、腹腔鏡、嗜鉻細胞瘤
(高雄醫誌 2009;25:438–44)
